Phase 1 × Central Nervous System Neoplasms × Temozolomide × Clear all Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
33 enrolled 15 charts
PIRATE
Phase 1 Terminated
2 enrolled
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Phase 1 Completed
30 enrolled 19 charts
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Phase 1 Completed
26 enrolled 16 charts
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Phase 1 Completed
28 enrolled
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Phase 1 Terminated
15 enrolled
Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Phase 1 Completed
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
24 enrolled
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
Phase 1 Completed
12 enrolled
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
Phase 1 Completed
34 enrolled
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
45 enrolled
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
Phase 1 Completed
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
Phase 1 Unknown
30 enrolled
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
Phase 1 Unknown
28 enrolled
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Phase 1 Completed
Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
Phase 1 Completed
32 enrolled
Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
Phase 1 Completed
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Phase 1 Completed
65 enrolled
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Phase 1 Completed
25 enrolled
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
50 enrolled
CN-306
Phase 1 Terminated
2 enrolled
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
Phase 1 Completed
26 enrolled
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
Phase 1 Terminated
14 enrolled
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
Phase 1 Completed
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
Phase 1 Completed
18 enrolled
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Terminated
8 enrolled